Skip to content

Mentor Integration Study

Mentor Integration Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00468468
Enrollment
126
Registered
2007-05-02
Start date
2003-09-30
Completion date
2008-09-30
Last updated
2016-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHESS and Cancer Mentor, CHESS Only, Control (Internet Only), Mentor Only

Keywords

breast cancer, Internet, computer, support, information, education

Brief summary

Mentor Integration Project This study will investigate the benefits of CHESS, a Human Cancer Mentor and the potential additional benefit of combining CHESS and a Cancer Mentor compared to Internet access for women diagnosed with breast cancer. Our goal is to advance interactive cancer communication systems, thus improving quality of life for patients and families facing cancer, especially underserved populations. Primary Aims: * Determine if the Internet, CHESS, a Cancer Mentor, or a combination of CHESS and the Cancer Mentor improve quality of life for women with breast cancer * Determine which of the above conditions is most effective * Determine which of the above conditions is most cost efficient

Interventions

BEHAVIORALCHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor

computer based education and support

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility for this protocol is as follows: * All subjects must be within 2 months of their primary breast cancer diagnosis, * All subjects must be at least 18 years of age, * All subjects must be able to read and write English at the 6th-grade level * Not homeless

Design outcomes

Primary

MeasureTime frame
Patient quality of lifethroughout study

Secondary

MeasureTime frame
Self efficacythroughout study
Emotional well beingthroughout study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026